Answers are grounded in this paper and cite their sources.
Randomized trial examines impact of WASH and nutritional interventions on IgG immune responses in children, indicating the need for additional vaccines.
We studied the effects of a combined water, sanitation, handwashing, and nutritional supplementation (WSH + N) intervention on Shigella /EIEC IgG immune development among Bangladeshi children enrolled in a cluster-randomized trial. We used a bacterial display assay to measure IgG-specific binding to Shigella /EIEC Ipa proteins (IpaA, IpaB, IpaC, IpaD, and IpaH) from a substudy of 120 children (60 intervention, 60 control) at median ages 3, 14, and 28 months. We found that the WSH + N intervention did not impact IgG seroprevalence (56% vs 53%, P = 0.6) or IgG epitope repertoire development ( P = 0.15–0.97), but there were distinct age-based patterns of IgG linear epitopes and motifs charting the development of the immune repertoire. Samples from before age 6 months, reflecting predominantly maternal IgG, had higher epitope breadth and magnitude compared with samples from older ages. A modeling analysis of maternal-child IgG dynamics suggests that peak susceptibility occurs between 6 and 9 months of age. With this methodology, we found that intensive, household-based WASH interventions were insufficient to impact early childhood immune development to Shigella /EIEC. Our results motivate complementary interventions, such as vaccines, to prevent Shigella /EIEC infection in the first 2 years of life. IMPORTANCE Shigella /EIEC is a leading cause of global diarrheal deaths, especially in low-resource settings. Current interventions against childhood Shigella /EIEC infection focus on reducing exposure, such as through improved water, sanitation, handwashing, and nutritional supplementation (WSH + N). It is unclear how these interventions impact childhood immune development against pathogens. In the present study, we characterize the null impact of a WSH + N intervention on IgG immune responses to Shigella /EIEC in a birth cohort and demonstrate the development of immune responses over the first 2 years of life. We found that maternal IgG wanes between 6 and 9 months, and that peak susceptibility to infection is during this time. From our findings, we provide a modeling framework that can be used to inform vaccination schedules in early childhood after 6 months. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT01590095 .
No takes yet. Share an insight, caveat, or question.
Walas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: